Canaccord analyst Matt Bottomley lowered the firm’s price target on Aurora Cannabis to C$1.50 from C$2.00 and keeps a Hold rating on the shares. The analyst said our lowered valuation is not related directly to FQ2 results but more a function of increased sector risk, which, although not necessarily core to the overall ACB strategy, nonetheless slightly weighs on our overall SOTP analysis.
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Published first on TheFly
See the top stocks recommended by analysts >>
Read More on ACB:
